Petros Christopoulos

35PUBLICATIONS
219CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Oct 14, 2026
Second- and third-line outcomes after selective RET inhibitor failure in RET fusion-positive metastatic lung cancer: A real-world analysis from the RET-MAP registry.

|Sep 26, 2026
Current Management and the New Paradigm for ALK+ NSCLC After CROWN.

|Jul 28, 2026
Durvalumab Consolidation After Definitive Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer: A Real-World Cohort Analysis from the German Prospective, Observational CRISP Registry (AIO-TRK-0315).

|May 19, 2026
Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group.

|Mar 27, 2026
Real-World Treatment Patterns and Survival in Patients with ROS1-Positive Advanced Non-Small Cell Lung Cancer in Canada and Europe.

Winson Y Cheung, Adam Lee, Helena Bote de Cabo

|Jan 13, 2026
Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples.

Markus Ball, Susanne Beck, Darius Wlochowitz

Pageof 6

Frequent Collaborators

5 joint publications

Albrecht Stenzinger

5 joint publications

Daniel Kazdal

3 joint publications

Jan Budczies

3 joint publications

Olaf Neumann